Addolorato, G, Leggio, L, Ferrulli, A et al (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet, 370: 1915–22.
Anton, RF, O'Malley, SS, Ciraulo, DA et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study. A randomized controlled trial. JAMA, 295: 2003–17.
Beck, T, Haasen, C, Verthein, U et al (2014) Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized crossover, non-inferiority study versus methadone. Addiction, 109: 617–26.
Beer, B, Rabl, W, Libiseller, K et al (2010) [Impact of slow-release oral morphine on drug abusing habits in Austria] [article in German]. Neuropsychiatry, 24: 108–17.
Bouza, C, Angeles, M, Muñoz, A et al (2004) Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction, 99: 811–28.
Byford, S, Barrett, B, Metrebian, N et al (2013) Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. British Journal of Psychiatry, 203: 341–9.
Chick, J, Gough, K, Falowski, W et al (1992) Disulfiram treatment of alcoholism. British Journal of Psychiatry, 161: 84–9.
Comer, SD, Sullivan, MA, Yu, E et al (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomised, placebo-controlled trial. Archives of General Psychiatry, 63: 210–8.
Davoli, M, Bargagli, AM, Perucci, CA et al (2007) Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction, 102: 1954–9.
Department of Health (England) and the devolved administrations (2007) Drug Misuse and Dependence: UK Guidelines on Clinical Management. Department of Health (England), Scottish Government, Welsh Assembly Government and Northern Ireland Executive.
de Sousa, A, De Sousa, A (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol and Alcoholism, 39: 528–31.
de Sousa, A, De Sousa, A (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism, 40: 545–8.
Eder, H, Jagsch, R, Kraigher, D et al (2005) Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction, 100: 1101–9.
Ferri, M, Minozzi, S, Bo, A et al (2013) Slow-release oral morphine as maintenance therapy for opioid dependence. Cochrane Database of Systematic Reviews, 6: CD009879.
Fiellin, DA, Pantalon, MV, Chawarski, MC et al (2006) Counseling plus buprenorphine–naloxone maintenance therapy for opioid dependence. New England Journal of Medicine, 355: 365–74.
Garbutt, JC, Kampov-Polevoy, AB, Gallop, R et al (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcoholism: Clinical and Experimental Research, 34: 1849–57.
Hser, YI, Saxon, AJ, Huang, D et al (2013) Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction, 109: 79–87.
Hughes, JC, Cook, CC (1997) The efficacy of disulfiram: a review of outcome studies. Addiction, 92: 381–95.
Hulse, GK, Morris, N, Arnold-Reed, D et al (2009) Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Archives of General Psychiatry, 66: 1108–15.
Joint Formulary Committee (2014) British National Formulary (68). BMJ Group & Pharmaceutical Press.
Johnsen, J, M⊘rland, J (1991) Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcoholism, Clinical and Experimental Research, 15: 532–6.
Kakko, J, Grönbladh, L, Svanborg, KD et al (2007) A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. American Journal of Psychiatry, 164: 797–803.
Koesters, M, Becker, T, Killian, R (2009) Limits of meta-analysis: methylphenidate in the treatment of adult ADHD. Psychiatric Clinics of North America, 23: 733–44.
Konstenius, M, Jayaram-Lindström, N, Guterstam, J et al (2014) Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction, 109: 440–9.
Krampe, H, Ehrenreich, H (2010) Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Current Pharmaceutical Design, 16: 2076–90.
Lobmaier, P, Kornor, H, Kunoe, N et al (2008) Sustained-release naltrexone for opioid dependence. Cochrane Database of Systematic Reviews, 2: CD006140.
Luty, J (2003) What works in drug addiction?
Advances in Psychiatric Treatment, 9: 280–8.
Luty, J (2006) What works in alcohol use disorders?
Advances in Psychiatric Treatment, 12: 13–22.
Luty, J (2014) Drug and alcohol addiction: new challenges. Advances in Psychiatric Treatment, 20: 413–21.
Magon, R, Müller, U (2012) ADHD with comorbid substance use disorder: review of treatment. Advances in Psychiatric Treatment, 18: 436–46.
Mann, K, Lehert, P, Morgan, MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcoholism: Clinical and Experimental Research, 28: 51–63.
Mann, K, Bladström, A, Torup, L et al (2013) Extending the treatment of options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biological Psychiatry, 73: 706–13.
Mason, BJ, Salvato, FR, Williams, LD (1999) A double-blind placebo controlled study of oral nalmefene for alcohol dependence. Archives of General Psychiatry, 56: 719–24.
Mattick, R P., Kimber, J, Breen, C et al (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2: CD002207.
Miles, SW, Sheridan, J, Russell, B et al (2013) Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction, 108: 1279–86.
Minozzi, S1, Amato, L, Vecchi, S et al (2011) Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews, 4: CD001333.
National Institute for Health and Clinical Excellence (2008) Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults (NICE Clinical Guideline 72). NICE.
National Treatment Agency for Substance Misuse (2003) Injectable Heroin (and Injectable Methadone): Potential Roles in Drug Treatment. Full Guidance Report. National Treatment Agency.
Nutt, DJ, Fone, K, Asherson, P et al (2007) Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 21: 10–41.
Pani, PP1, Trogu, E, Vacca, R et al (2010) Disulfiram for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews, 1: CD007024.
Pinto, H, Maskrey, V, Swift, L et al (2010) The SUMMIT Trial: a field comparison of buprenorphine versus methadone maintenance treatment. Journal of Substance Abuse Treatment, 39: 340–52.
Raistrick, D, West, D, Finnegan, O et al (2005) A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial. Addiction, 100: 1860–7.
Robertson, JR, Raab, GM, Bruce, M et al (2006) Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial. Addiction, 101: 1752–9.
Rösner, S, Hackl-Herrwerth, A, Leucht, S et al (2010) Naltrexone and nalmefene for alcohol dependent patients. Cochrane Database of Systematic Reviews, 12: CD001867.
Rösner, S, Hackl-Herrwerth, A, Leucht, S et al (2011) Acamprosate for alcohol dependent patients. Cochrane Database of Systematic Reviews, 9: CD004332.
Strang, J, Metrebian, N, Lintzeris, N et al (2010) Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet, 375: 1885–95.
Suh, JJ, Pettinati, HM, Kampman, KM et al (2006) The status of disulfiram: a half of a century later. Journal of Clinical Psychopharmacology, 26: 290–302.
Wilens, TE, Adler, LA, Adams, J et al (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry, 47: 21–31.
Winstock, AR, Lea, T, Sheridan, J (2008) Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy, 19: 450–8.